Literature DB >> 400730

Insulin receptors in human endothelial cells: identification and characterization.

R S Bar, J C Hoak, M L Peacock.   

Abstract

Specific binding of 125I-insulin was found in cultured human endothelial cells obtained from human umbilical veins. The binding reaction was rapid and reversible, demonstrated receptor site-site interactions of the negatively cooperative type, and was dependent on the temperature, pH and duration of incubation. At 21 degrees C, steady-state conditions of binding occurred in 90 minutes, the pH optimum was 7.8 and less than 10% of the labeled hormone was degraded. Binding of tracer amounts of 125I-insulin was inhibited by concentrations of unlabeled insulin as low as 0.2 ng/ml and 50% inhibition was obtained at 2-5 ng/ml of unlabeled insulin. Unlabeled porcine insulin, porcine proinsulin and desoctapeptide insulin inhibited the binding of 125I-porcine insulin in direct proportion to their biological potencies, whereas to the cells was inhibited by antibodies against insulin receptors. We conclude that human endothelial cells possess specific receptors for insulin whose physio-chemical properties are similar to those of insulin receptors in other tissues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 400730     DOI: 10.1210/jcem-47-3-699

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Insulin modulates inflammatory and repair responses to elastase-induced emphysema in diabetic rats.

Authors:  Antonio Di Petta; Karin V Greco; Eveline O Castro; Fernanda D T Q S Lopes; Milton A Martins; Vera L Capelozzi; Luiz F P Moreira; Paulina Sannomiya
Journal:  Int J Exp Pathol       Date:  2011-09-22       Impact factor: 1.925

2.  Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

Authors:  G Zeng; M J Quon
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Insulin permeability across an in vitro dynamic model of endothelium.

Authors:  Francesca Salvetti; Paolo Cecchetti; Damir Janigro; Antonio Lucacchini; Luca Benzi; Claudia Martini
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

4.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.

Authors:  R L Prigeon; M E Røder; D Porte; S E Kahn
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

5.  The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues.

Authors:  D Turk; A Alzaid; S Dinneen; K S Nair; R Rizza
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

6.  A role for heterotrimeric GTP-binding proteins and ERK1/2 in insulin-mediated, nitric-oxide-dependent, cyclic GMP production in human umbilical vein endothelial cells.

Authors:  O Konopatskaya; A C Shore; J E Tooke; J L Whatmore
Journal:  Diabetologia       Date:  2005-03-01       Impact factor: 10.122

7.  Binding, internalization, and degradation of [125I]insulin by cultured bovine aortic endothelial cells: effects of serotonin.

Authors:  M P Carson; S W Peterson; M E Moynahan; D Shepro
Journal:  In Vitro       Date:  1983-11

8.  Insulin receptors in syncytiotrophoblast and fetal endothelium of human placenta. Immunohistochemical evidence for developmental changes in distribution pattern.

Authors:  G Desoye; M Hartmann; A Blaschitz; G Dohr; T Hahn; G Kohnen; P Kaufmann
Journal:  Histochemistry       Date:  1994-04

9.  Vascular transport of insulin to rat cardiac muscle. Central role of the capillary endothelium.

Authors:  R S Bar; M Boes; A Sandra
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

10.  Insulin transport across capillaries is rate limiting for insulin action in dogs.

Authors:  Y J Yang; I D Hope; M Ader; R N Bergman
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.